Search research articles
Contact Us
Filters
Showing results (81-90 of 242) with videos related to
Page
of 25
Sort By:
Frontiers in Cardiovascular Medicine
|
February 14, 2022
Soluble Urokinase Plasminogen Activator Receptor Is Associated With Subclinical Myocardial Impairment by Speckle Tracking Echocardiography in Lung Cancer Patients
Ahmad S Manshad, Fatima A Ballout, Jeffrey A Borgia, et al.
Critical Care (London, England)
|
May 2, 2020
Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
Nikoletta Rovina, Karolina Akinosoglou, Jesper Eugen-Olsen, et al.
Journal of the American Society of Nephrology : JASN
|
February 22, 2001
Podocytes respond to mechanical stress in vitro
Nicole Endlich, Kai R Kress, Jochen Reiser, et al.
Annals of Translational Medicine
|
December 13, 2016
Drugs targeting dynamin can restore cytoskeleton and focal contact alterations of urinary podocytes derived from patients with nephrotic syndrome
Janina Müller-Deile, Beina Teng, Heiko Schenk, et al.
Journal of Clinical Medicine
|
October 6, 2018
Fetal Renal Echogenicity Associated with Maternal Focal Segmental Glomerulosclerosis: The Effect of Transplacental Transmission of Permeability Factor suPAR
Shirley Shuster, Ghada Ankawi, Christoph Licht, et al.
Plos One
|
November 22, 2013
Cellular effects of everolimus and sirolimus on podocytes
Sandra Müller-Krebs, Lena Weber, Julia Tsobaneli, et al.
The EMBO Journal
|
October 12, 2010
Direct dynamin-actin interactions regulate the actin cytoskeleton
Changkyu Gu, Suma Yaddanapudi, Astrid Weins, et al.
The Journal of Clinical Investigation
|
April 21, 2005
Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner
Katsuhiko Asanuma, Kwanghee Kim, Jun Oh, et al.
Pediatric Nephrology (Berlin, Germany)
|
February 5, 2010
Enzymatic disease of the podocyte
Andreas D Kistler, Vasil Peev, Anna-Lena Forst, et al.
Kidney International Reports
|
September 11, 2018
Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients
Claudia Torino, Patrizia Pizzini, Sebastiano Cutrupi, et al.
Page
of 25
Search research articles
Search
Showing results (81-90 of 242) with videos related to
Sort By:
Page
of 25
Frontiers in Cardiovascular Medicine
|
February 14, 2022
Soluble Urokinase Plasminogen Activator Receptor Is Associated With Subclinical Myocardial Impairment by Speckle Tracking Echocardiography in Lung Cancer Patients
Ahmad S Manshad, Fatima A Ballout, Jeffrey A Borgia, et al.
Critical Care (London, England)
|
May 2, 2020
Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
Nikoletta Rovina, Karolina Akinosoglou, Jesper Eugen-Olsen, et al.
Journal of the American Society of Nephrology : JASN
|
February 22, 2001
Podocytes respond to mechanical stress in vitro
Nicole Endlich, Kai R Kress, Jochen Reiser, et al.
Annals of Translational Medicine
|
December 13, 2016
Drugs targeting dynamin can restore cytoskeleton and focal contact alterations of urinary podocytes derived from patients with nephrotic syndrome
Janina Müller-Deile, Beina Teng, Heiko Schenk, et al.
Journal of Clinical Medicine
|
October 6, 2018
Fetal Renal Echogenicity Associated with Maternal Focal Segmental Glomerulosclerosis: The Effect of Transplacental Transmission of Permeability Factor suPAR
Shirley Shuster, Ghada Ankawi, Christoph Licht, et al.
Plos One
|
November 22, 2013
Cellular effects of everolimus and sirolimus on podocytes
Sandra Müller-Krebs, Lena Weber, Julia Tsobaneli, et al.
The EMBO Journal
|
October 12, 2010
Direct dynamin-actin interactions regulate the actin cytoskeleton
Changkyu Gu, Suma Yaddanapudi, Astrid Weins, et al.
The Journal of Clinical Investigation
|
April 21, 2005
Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner
Katsuhiko Asanuma, Kwanghee Kim, Jun Oh, et al.
Pediatric Nephrology (Berlin, Germany)
|
February 5, 2010
Enzymatic disease of the podocyte
Andreas D Kistler, Vasil Peev, Anna-Lena Forst, et al.
Kidney International Reports
|
September 11, 2018
Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients
Claudia Torino, Patrizia Pizzini, Sebastiano Cutrupi, et al.
Page
of 25